212 related articles for article (PubMed ID: 29201448)
1. Neuroendocrine tumors of the thymus and mediastinum.
Bohnenberger H; Dinter H; König A; Ströbel P
J Thorac Dis; 2017 Nov; 9(Suppl 15):S1448-S1457. PubMed ID: 29201448
[TBL] [Abstract][Full Text] [Related]
2. Molecular Classification of Neuroendocrine Tumors of the Thymus.
Dinter H; Bohnenberger H; Beck J; Bornemann-Kolatzki K; Schütz E; Küffer S; Klein L; Franks TJ; Roden A; Emmert A; Hinterthaner M; Marino M; Brcic L; Popper H; Weis CA; Pelosi G; Marx A; Ströbel P
J Thorac Oncol; 2019 Aug; 14(8):1472-1483. PubMed ID: 31042566
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of neuroendocrine lung tumor classification.
Travis WD; Gal AA; Colby TV; Klimstra DS; Falk R; Koss MN
Hum Pathol; 1998 Mar; 29(3):272-9. PubMed ID: 9496831
[TBL] [Abstract][Full Text] [Related]
4. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
Schnabel PA; Junker K
Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
[TBL] [Abstract][Full Text] [Related]
5. Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.
Yliaska I; Tokola H; Ebeling T; Kuismin O; Ukkola O; Koivikko ML; Lesonen T; Rimpiläinen J; Felin T; Ryhänen E; Metso S; Schalin-Jäntti C; Salmela P
Endocrine; 2022 Sep; 77(3):527-537. PubMed ID: 35696052
[TBL] [Abstract][Full Text] [Related]
6. [Thymic neuroendocrine tumors: report on 6 cases].
Chalabreysse L; Gengler C; Sefiani S; Meyronet D; Thivolet-Béjui F
Ann Pathol; 2005 Jun; 25(3):205-10. PubMed ID: 16230946
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid.
Travis WD; Rush W; Flieder DB; Falk R; Fleming MV; Gal AA; Koss MN
Am J Surg Pathol; 1998 Aug; 22(8):934-44. PubMed ID: 9706973
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence.
Grøndahl V; Binderup T; Langer SW; Petersen RH; Nielsen K; Kjaer A; Federspiel B; Knigge U
Lung Cancer; 2019 Jun; 132():141-149. PubMed ID: 31097087
[TBL] [Abstract][Full Text] [Related]
9. Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine.
Travis WD
Thorac Surg Clin; 2014 Aug; 24(3):257-66. PubMed ID: 25065926
[TBL] [Abstract][Full Text] [Related]
10. The surgical spectrum of pulmonary neuroendocrine neoplasms.
Cooper WA; Thourani VH; Gal AA; Lee RB; Mansour KA; Miller JI
Chest; 2001 Jan; 119(1):14-8. PubMed ID: 11157578
[TBL] [Abstract][Full Text] [Related]
11. Advances in neuroendocrine lung tumors.
Travis WD
Ann Oncol; 2010 Oct; 21 Suppl 7():vii65-71. PubMed ID: 20943645
[TBL] [Abstract][Full Text] [Related]
12. Primary neuroendocrine carcinomas of the mediastinum: review of current criteria for histopathologic diagnosis and classification.
Moran CA
Semin Diagn Pathol; 2005 Aug; 22(3):223-9. PubMed ID: 16711403
[TBL] [Abstract][Full Text] [Related]
13. What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?
Pelosi G; Fabbri A; Cossa M; Sonzogni A; Valeri B; Righi L; Papotti M
Semin Diagn Pathol; 2015 Nov; 32(6):469-79. PubMed ID: 26561395
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
Langfort R; Rudziński P; Burakowska B
Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
[TBL] [Abstract][Full Text] [Related]
15. hASH1 is a specific immunohistochemical marker for lung neuroendocrine tumors.
Ye B; Cappel J; Findeis-Hosey J; McMahon L; Yang Q; Xiao GQ; Xu H; Li F
Hum Pathol; 2016 Feb; 48():142-7. PubMed ID: 26596584
[TBL] [Abstract][Full Text] [Related]
16. Lung neuroendocrine tumors: pathological characteristics.
Righi L; Gatti G; Volante M; Papotti M
J Thorac Dis; 2017 Nov; 9(Suppl 15):S1442-S1447. PubMed ID: 29201447
[TBL] [Abstract][Full Text] [Related]
17. Bronchopulmonary neuroendocrine tumors.
Gustafsson BI; Kidd M; Chan A; Malfertheiner MV; Modlin IM
Cancer; 2008 Jul; 113(1):5-21. PubMed ID: 18473355
[TBL] [Abstract][Full Text] [Related]
18. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary neuroendocrine tumors: an entity in search of cytologic criteria.
Huang CC; Collins BT; Flint A; Michael CW
Diagn Cytopathol; 2013 Aug; 41(8):689-96. PubMed ID: 23166111
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of neuroendocrine lung tumors.
Sánchez de Cos Escuín J
Arch Bronconeumol; 2014 Sep; 50(9):392-6. PubMed ID: 24685201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
